(Q37274138)

19 August 2017

1 reference

title

To BCG or not to BCG? Preventing travel-associated tuberculosis in children (English)

1 reference

19 August 2017

0 references

1

1 reference

19 August 2017

3

1 reference

19 August 2017

Tom G Connell

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

17 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

26

1 reference

19 August 2017

issue

47

1 reference

19 August 2017

page(s)

5905-5910

1 reference

Global incidence of multidrug-resistant tuberculosis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Risk of travel-associated tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Tuberculosis in association with travel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Tuberculosis in travellers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Does neonatal BCG vaccination protect against tuberculous meningitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

The effectiveness of bacillus Calmette-Guérin (BCG) vaccination against tuberculosis. A case-control study in Treaty Indians, Alberta, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

A case-control study of BCG and childhood tuberculosis in Cali, Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Risk factors for latent tuberculosis infection among children in New York City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

BCG vaccine: efficacy and indications for vaccination and revaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.061

10.1016/J.VACCINE.2008.08.061

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference